I-STAT CTNI CARTRIDGE
Report
- Report Number
- 2245578-2008-00056
- Event Type
- Malfunction
- Date Received
- August 5, 2008
- Date of Event
- July 27, 2008
- Report Date
- August 5, 2008
- Manufacturer
- ABBOTT POINT OF CARE INC.
- Product Code
- MMI
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
ABBOTT HAS COMPLETED ITS TESTING OF HEPARIN LOTS FOR PRODUCTS MEETING THE CRITERIA FOR A 5-DAY MDR AS DESCRIBED IN THE FDA'S NOTICE DATED APRIL 8, 2008 [TO MANUFACTURERS AND INITIAL DISTRIBUTORS OF MEDICAL DEVICES THAT MAY CONTAIN HEPARIN OR ARE HEPARIN-COATED]. THE HEPARIN LOTS IDENTIFIED IN THE APOC MANUFACTURING PROCESS HAVE PASSED THE NUCLEAR MAGNETIC RESONANCE (NMR) AND CAPILLARY ELECTROPHORESIS (CE) TESTS. BECTON DICKINSON (BD) TUBE TESTING WILL COMMENCE PENDING THE APPROVAL, BY FDA, OF THE PROTOCOL.
THIS PRODUCT MEETS THE CRITERIA FOR A 5-DAY MDR AS DESCRIBED IN THE FDA'S NOTICE DATED APRIL 8, 2008 [TO MANUFACTURERS AND INITIAL DISTRIBUTORS OF MEDICAL DEVICES THAT MAY CONTAIN HEPARIN OR ARE HEPARIN-COATED], AND ABBOTT IS SUBMITTING THIS 5-DAY MDR. OUR INVESTIGATION INTO THIS EVENT IS ONGOING AND A SUPPLEMENTAL MDR WILL BE SUBMITTED AT THE CONCLUSION OF OUR INVESTIGATION. IN 2008, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER WHO REPORTED AT 20:35 USING AN I-STAT CARDIAC TROPONIN I CARTRIDGE YIELDED A RESULT OF 1.93 NG/ML. REPEATED SAME SAMPLE AT 20:54 USING AN I-STAT CARDIAC TROPONIN I CARTRIDGE YIELDED A RESULT OF 0.01 NG/ML. NEW SAMPLE DRAWN, AND TESTED AT 00:20 THE NEXT DAY USING A I-STAT CARDIAC TROPONIN I CARTRIDGE YIELDED A RESULT OF 0.00 NG/ML. NEW SAMPLE DRAWN, AND TESTED AT 03:45 USING LABORATORY EQUIPMENT YIELDED A RESULT OF 0.01 NG/ML. BD VACUTAINER, LOT 8082221.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | I-STAT CTNI CARTRIDGE | IVD | MMI | ABBOTT POINT OF CARE INC. | NA | T08111B |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 49 YR |